Companies: 10,795·Total market cap: $144.5T
Lumos Pharma, Inc.

Lumos Pharma, Inc.

LUMONASDAQHealthcare
$4.34
+$0.00(+0.00%)
Market Cap$37535011
P/E Ratio
52W High$4.5756
52W Low$1.3701
Overview

Lumos Pharma, Inc. (LUMO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

lumo · stock forecast · 7 analysts (3M) · FMP · updated Apr 25, 2025

Analyst Rating & Consensus

Based on 7 Wall Street analysts in the past 3 months

SellBuy

Buy

7 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
4
Hold
3
Sell
0
Strong Sell
0
Total: 7 · Buy rate: 57.1%

12-Month Price Target

High

$26.00

Consensus

$16.50

+280.2% upside

Low

$7.00

Median: $16.5 · Last Close: $4.34

The Lumos Pharma, Inc. (LUMO) analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month LUMO price target is $16.50, representing +280.2% upside from the current price of $4.34.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $17 (280.2%)

Consensus Target

$16.50

280.2% upside

High Target

$26

499.1%

Low Target

$7

61.3%

Current Price

$4.34

as of today

Based on analyst price targets, the LUMO stock price prediction for the next 12 months ranges from $7 to $26. The consensus LUMO price forecast of $16.50 implies 280.2% upside from the current price of $4.34.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$4.340.07%

1-day model range: $4.34–$4.35. Peak: $4.35 (+0.07%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$4-4.8%
2028$4-7.1%
2029$4-8.2%
2030$4-8.7%
2031-9.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

86%7%7%
12Buy
1Neutral
1Sell
RSI (14)57.1Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · LUMO · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$4.34BUY
MA 10$4.34SELL
MA 20$4.33BUY
MA 50$4.22BUY
MA 100$3.69BUY
MA 200$3.10BUY
Current $LUMO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.34BUY
EMA 10$4.34BUY
EMA 20$4.32BUY
EMA 50$4.16BUY
EMA 100$3.80BUY
EMA 200$3.47BUY
Current $LUMO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2024-11-08
Maintains
NeutralNeutral
HC Wainwright & Co.2024-10-24
Downgrade ↓
BuyNeutral
Jones Trading2024-10-23
Downgrade ↓
BuyHold
HC Wainwright & Co.2024-09-27
Maintains
BuyBuy
Oppenheimer2024-08-02
Maintains
OutperformOutperform
HC Wainwright & Co.2024-03-20
Maintains
BuyBuy
HC Wainwright & Co.2024-03-08
Maintains
BuyBuy
Oppenheimer2024-03-08
Maintains
OutperformOutperform
Oppenheimer2023-12-11
Maintains
OutperformOutperform
HC Wainwright & Co.2023-12-07
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Lumos Pharma, Inc. (LUMO) stock. Of the recent 43 rating actions, 2 were upgrades and 6 were downgrades. 7 analysts currently cover LUMO.

Analyst Recommendation Trends

Buy ratings202
Hold ratings01↑ +1
Sell ratings00

LUMO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1M

↑ 18.0% YoY

Revenue Next Year

$1M

↑ 15.7% YoY

EPS This Year

$-3.71

EPS Next Year

$-1.91

↓ 48.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LUMO EPS of $-3.71 for the current fiscal year, based on estimates from 1 analysts. The LUMO revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The LUMO stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LUMO price target is $16.50 (+280.2% upside), with an analyst consensus of Buy.

The LUMO short-term stock prediction for tomorrow is $4.34 (+0.07%). The LUMO stock price prediction for 2027 estimates an average of $4. The LUMO stock prediction for 2030 projects a range of $4–$4.

Lumos Pharma, Inc. trades on NASDAQ under the ticker LUMO. The LUMO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

LUMO forecast · 8 questions

According to 7 Wall Street analysts, the average 12-month LUMO price target is $16.50, with a high forecast of $26.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +280.2% potential upside from the current price of $4.34.

LUMO price targetWhat is LUMO price targetLUMO analyst price targetLUMO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.